BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34468797)

  • 21. Indirect comparison of the diagnostic performance of
    Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J
    BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of benignity of solid adnexal masses.
    Wang S; Johnson S
    Arch Gynecol Obstet; 2012 Mar; 285(3):721-6. PubMed ID: 21858439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of CT signs for predicting adnexal torsion in women presenting with an adnexal mass and abdominal pain: A case-control study.
    Mandoul C; Verheyden C; Curros-Doyon F; Rathat G; Taourel P; Millet I
    Eur J Radiol; 2018 Jan; 98():75-81. PubMed ID: 29279174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adnexal Lesion Imaging: Past, Present, and Future.
    Sadowski EA; Rockall A; Thomassin-Naggara I; Barroilhet LM; Wallace SK; Jha P; Gupta A; Shinagare AB; Guo Y; Reinhold C
    Radiology; 2023 Jun; 307(5):e223281. PubMed ID: 37158725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADC-derived spatial features can accurately classify adnexal lesions.
    Fathi Kazerooni A; Nabil M; Haghighat Khah H; Alviri M; Heidari-Sooreshjaani M; Gity M; Malek M; Saligheh Rad H
    J Magn Reson Imaging; 2018 Apr; 47(4):1061-1071. PubMed ID: 28901638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid lesions visualized on CT: sonographic and pathologic correlation.
    Lee C; Chalmers B; Treister D; Adhya S; Godwin B; Ji L; Groshen S; Grant E
    Acad Radiol; 2015 Feb; 22(2):203-9. PubMed ID: 25262956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidetector computed tomography for the assessment of adnexal mass: is unenhanced CT scan necessary?
    Jung SI; Park HS; Kim YJ; Jeon HJ
    Korean J Radiol; 2014; 15(1):72-9. PubMed ID: 24497795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-detector CT features of benign adnexal lesions.
    Tsili AC; Dalkalitsis N; Paraskevaidis E; Tsampoulas K
    Acad Radiol; 2010 Jan; 17(1):31-8. PubMed ID: 19734064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.
    Timmerman D; Ameye L; Fischerova D; Epstein E; Melis GB; Guerriero S; Van Holsbeke C; Savelli L; Fruscio R; Lissoni AA; Testa AC; Veldman J; Vergote I; Van Huffel S; Bourne T; Valentin L
    BMJ; 2010 Dec; 341():c6839. PubMed ID: 21156740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer.
    Varras M
    Clin Exp Obstet Gynecol; 2004; 31(2):85-98. PubMed ID: 15266758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating between benign and malignant adnexal lesions with contrast-enhanced transvaginal ultrasonography.
    Szymanski M; Socha MW; Kowalkowska ME; Zielińska IB; Eljaszewicz A; Szymanski W
    Int J Gynaecol Obstet; 2015 Nov; 131(2):147-51. PubMed ID: 26254725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian malignancy in breast cancer patients with an adnexal mass.
    Simpkins F; Zahurak M; Armstrong D; Grumbine F; Bristow R
    Obstet Gynecol; 2005 Mar; 105(3):507-13. PubMed ID: 15738016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adnexal masses in women with breast cancer.
    Tuncer ZS; Boyraz G; Selcuk I; Sahin N; Kaynaroğlu V; Ozışık Y
    Aust N Z J Obstet Gynaecol; 2012 Jun; 52(3):266-9. PubMed ID: 22486200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models.
    Ng CS; Wei W; Altinmakas E; Li X; Ghosh P; Perrier NA; Grubbs E; Prieto VG; Lee JE; Hobbs BP
    AJR Am J Roentgenol; 2018 Apr; 210(4):W156-W163. PubMed ID: 29412015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence.
    Ruiz de Gauna B; Rodriguez D; Olartecoechea B; Aubá M; Jurado M; Gómez Roig MD; Alcázar JL
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():10-4. PubMed ID: 26066289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.